| Literature DB >> 29187713 |
Yang Lv1, Xueni Li1, Lin Zhang2, Yutao Shi1, Linxiao DU1, Binying Ding1, Yongqing Hou1, Joshua Gong1,3, Tao Wu1.
Abstract
Enterotoxigenic Escherichia coli (ETEC) is primary pathogenic bacteria of piglet diarrhea, over two thirds of piglets diarrhea caused by ETEC are resulted from STa-producing ETEC strains. This experiment was conducted to construct the recombinant E. coli expressing STa and study the injury and mechanism of recombinant E. coli expressing STa on 7 days old piglets colon. Twenty-four 7 days old piglets were allotted to four treatments: control group, STa group (2 × 109 CFU E. coli LMG194-STa), LMG194 group (2 × 109 CFU E. coli LMG194) and K88 group (2 × 109 CFU E. coli K88). The result showed that E. coli infection significantly increased diarrhea rates; changed DAO activity in plasma and colon; damaged colonic mucosal morphology including crypt depth, number of globet cells, density of lymphocytes and lamina propria cell density; substantially reduced antioxidant capacity by altering activities of GSH-Px, SOD, and TNOS and productions of MDA and H2O2; obviously decreased AQP3, AQP4 and KCNJ13 protein expression levels; substantially altered the gene expression levels of inflammatory cytokines. Conclusively, STa group had the biggest effect on these indices in four treatment groups. These results suggested that the recombinant strain expressed STa can induce piglets diarrhea and colonic morphological and funtional damage by altering expression of proteins connect to transportation function and genes associated with intestinal injury and inflammatory cytokines.Entities:
Keywords: colon; heat-stable enterotoxin A; piglet; recombinant escherichia coli
Mesh:
Substances:
Year: 2017 PMID: 29187713 PMCID: PMC5836754 DOI: 10.1292/jvms.17-0528
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Fig 1.Construction of the recombinant E. coli LMG194-STa. A) Amplification of STa by PCR (216 bp) M: DL2000 Marker. B) Verification of pBAD-STa by enzyme digestion (393+216 bp) M: DL2000 Marker.
Nutrition-allocated proportion of milk-substitutes
| Composition | Contents | Composition | Contents |
|---|---|---|---|
| Crude Protein /% | ≥20.0 | Crude Fiber /% | ≤0.3 |
| Ether Extract /% | ≤10.0 | Calcium /% | 0.4–1.1 |
| Crude Ash /% | ≤9.0 | Total Phosphorus /% | ≥0.3 |
| Water /% | ≤10.0 | Lysine /% | ≥1.4 |
Primers for Real-Time PCR analysis
| Gene | Primers | Gene code |
|---|---|---|
| RPL4 | 5′-GAGAAACCGTCGCCGAAT-3′ | XM_005659862 |
| 5′-GCCCACCAGGAGCAAGTT-3′ | ||
| Villin | 5′-TATTATTGGTGTTCGTGCTA-3′ | YMD14268 |
| 5′-TCTGGAGGAATAGGATACTAA-3′ | ||
| MMP3 | 5′-GATGTTGGTTACTTCAGCAC-3′ | YMD14303 |
| 5′-ATCATTATGTCAGCCTCTCC-3′ | ||
| I-FABP | 5′-AGATAGACCGCAATGAGA-3′ | YMD14286 |
| 5′-TCCTTCTTGTGTAATTATCATCAGT-3′ | ||
| IL-4 | 5′-AGGAGCCACACGTGCTTGA-3′ | M77120 |
| 5′-TTGCCAAGCTGTTGAGATTCC-3′ | ||
| IFN-γ | 5′-TCTGGGAAACTGAATGACTTCG-3′ | YMD14356 |
| 5′-GACTTCTCTTCCGCTTTCTTAGGTT-3′ | ||
| CCL2 | 5′-CATAAGCCACCTGGACAAGAAAA-3′ | NM-214214 |
| 5′-GGGTATTTAGGGCAAGTTAGAAGGA-3′ | ||
| CXCL9 | 5′-CTTGCTTTTGGGTATCATCTTCCT-3′ | NM_001114289 |
| 5′-TCATCCTTTGGCTGGTGTTG-3′ | ||
| HSPH-1 | 5′-ATGAGCACGGCTTCATTTCC-3′ | NM_001007518 |
| 5′-GGGCTTTTCCGACTTTCCA-3′ | ||
| VNN1 | 5′-ATGGATGTGTCGCTGGTCTTT-3′ | NM_004666 |
| 5′-CACAACTGCTTGCCTTTACGAG-3′ |
The rate of piglet diarrhea
| Items | Control group | STa group | LMG194 group | K88 group |
|---|---|---|---|---|
| Before challenge (%) | 22.2 | 5.6 | 5.6 | 11.1 |
| After challenge (%) | 25.0a) | 91.7b) | 33.3a) | 91.7b) |
Data are mean ± SEM, n=6. a, b) Different letters differ significant (P<0.05).
Fig 2.Colonic mucosal morphology. a) control group, b) STa group, c) LMG194 group and d) K88 group.
Index of colonic mucosal morphology
| Items | Control group | STa group | LMG194 group | K88 group |
|---|---|---|---|---|
| Depth of crypt ( | 411.3 ± 52.4b) | 679.3 ± 41.6a) | 517.6 ± 52.3b) | 716.2 ± 61.1a) |
| Number of goblet cells | 7.0 ± 1.0b) | 17.0 ± 1.7a) | 9.5 ± 1.5b) | 16.5 ± 2.2a) |
| Number of lymphocytes | 59.5 ± 5.8 | 58.8 ± 6.2 | 57.3 ± 7.7 | 58.3 ± 6.7 |
| Lamina propria cell density (/mm2) | 527.4 ± 54.3a) | 674.4 ± 43.8c) | 550.2 ± 58.9a) | 694.7 ± 24.8b) |
| Density of lymphocyte (/mm2) | 711.9 ± 61.7b) | 546.7 ± 55.9a) | 613.5 ± 48.1a) | 595.5 ± 56.7a) |
Data are mean ± SEM, n=6. a–c) Different letters differ significant (P<0.05).
DAO activities in plasma and colon and antioxidant capacity in colon
| Items | Control group | STa group | LMG194 group | K88 group |
|---|---|---|---|---|
| DAO in plasma (U/m | 5.26 ± 1.05a) | 16.42 ± 1.49d) | 10.48 ± 2.99b) | 13.48 ± 1.60c) |
| DAO in colon (U/m | 0.74 ± 0.16a) | 0.52 ± 0.09b) | 0.59 ± 0.12b) | 0.68 ± 0.13ab) |
| SOD (U/mg) | 36.52 ± 4.41ab) | 31.16 ± 5.42c) | 33.11 ± 5.23bc) | 38.32 ± 4.61a) |
| GSH-Px (U/mg) | 197.29 ± 50.58a) | 140.85 ± 22.52b) | 132.15 ± 17.89b) | 136.98 ± 23.26b) |
| H2O2 (nmol/mg) | 9.34 ± 2.64b) | 12.93 ± 2.51a) | 10.57 ± 2.19ab) | 8.73 ± 1.65b) |
| MDA (nmol/mg) | 15.97 ± 5.91a) | 21.90 ± 5.42b) | 20.54 ± 5.62b) | 13.52 ± 4.78a) |
| TNOS (U/mg) | 1.59 ± 0.36a) | 0.91 ± 0.28b) | 0.81 ± 0.15b) | 0.87 ± 0.27b) |
a–d) Different letters differ significant (P<0.05).
Fig 4.Gene expression levels of villin, I-FABP and MMP3 in colonic mucosa.
Fig. 3.Protein expression levels of AQP3, AQP4 and KCNJ13 in colonic mucosa. Data are mean ± SEM, n=6. a-c Different letters differ significant (P<0.05), the same as below.
Fig. 5.Gene expression levels of inflammatory cytokines in colonic mucosa.